Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Immaculate Nevis is active.

Publication


Featured researches published by Immaculate Nevis.


Clinical Journal of The American Society of Nephrology | 2011

Pregnancy outcomes in women with chronic kidney disease: a systematic review.

Immaculate Nevis; Angela Reitsma; Arunmozhi Dominic; Sarah D. McDonald; Lehana Thabane; Elie A. Akl; Michelle A. Hladunewich; Ayub Akbari; Geena Joseph; Winnie Sia; Arthur V. Iansavichus; Amit X. Garg

BACKGROUND AND OBJECTIVES Pregnant women with chronic kidney disease (CKD) are at risk of adverse maternal and fetal outcomes. We conducted a systematic review of observational studies that described this risk. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS We searched several databases from their date of inception through June 2010 for eligible articles published in any language. We included any study that reported maternal or fetal outcomes in at least five pregnant women in each group with or without CKD. We excluded pregnant women with a history of transplantation or maintenance dialysis. RESULTS We identified 13 studies. Adverse maternal events including gestational hypertension, pre-eclampsia, eclampsia, and maternal mortality were reported in 12 studies. There were 312 adverse maternal events among 2682 pregnancies in women with CKD (weighted average of 11.5%) compared with 500 events in 26,149 pregnancies in normal healthy women (weighted average of 2%). One or more adverse fetal outcomes such as premature births, intrauterine growth restriction, small for gestational age, neonatal mortality, stillbirths, and low birth weight were reported in nine of the included studies. Overall, the risk of developing an adverse fetal outcome was at least two times higher among women with CKD compared with those without. CONCLUSIONS This review summarizes current available evidence to guide physicians in their decision-making, advice, and care for pregnant women with CKD. Additional studies are needed to better characterize the risks.


Journal of Clinical Epidemiology | 2013

The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses

Reem A. Mustafa; Nancy Santesso; Jan Brozek; Elie A. Akl; Stephen D. Walter; Geoff Norman; Mahan Kulasegaram; Robin Christensen; Gordon H. Guyatt; Yngve Falck-Ytter; Stephanie Chang; Mohammad Hassan Murad; Gunn Elisabeth Vist; Toby J Lasserson; Gerald Gartlehner; Vijay K. Shukla; Xin Sun; Craig Whittington; Piet N. Post; Eddy Lang; Kylie J Thaler; Ilkka Kunnamo; Heidi Alenius; Joerg J. Meerpohl; Ana C. Alba; Immaculate Nevis; Stephen J. Gentles; Marie Chantal Ethier; Alonso Carrasco-Labra; Rasha Khatib

OBJECTIVE We evaluated the inter-rater reliability (IRR) of assessing the quality of evidence (QoE) using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. STUDY DESIGN AND SETTING On completing two training exercises, participants worked independently as individual raters to assess the QoE of 16 outcomes. After recording their initial impression using a global rating, raters graded the QoE following the GRADE approach. Subsequently, randomly paired raters submitted a consensus rating. RESULTS The IRR without using the GRADE approach for two individual raters was 0.31 (95% confidence interval [95% CI] = 0.21-0.42) among Health Research Methodology students (n = 10) and 0.27 (95% CI = 0.19-0.37) among the GRADE working group members (n = 15). The corresponding IRR of the GRADE approach in assessing the QoE was significantly higher, that is, 0.66 (95% CI = 0.56-0.75) and 0.72 (95% CI = 0.61-0.79), respectively. The IRR further increased for three (0.80 [95% CI = 0.73-0.86] and 0.74 [95% CI = 0.65-0.81]) or four raters (0.84 [95% CI = 0.78-0.89] and 0.79 [95% CI = 0.71-0.85]). The IRR did not improve when QoE was assessed through a consensus rating. CONCLUSION Our findings suggest that trained individuals using the GRADE approach improves reliability in comparison to intuitive judgments about the QoE and that two individual raters can reliably assess the QoE using the GRADE system.


Kidney International | 2008

Chronic kidney disease and postoperative mortality: A systematic review and meta-analysis

Anna T. Mathew; Philip J. Devereaux; Ann M. O'Hare; Marcello Tonelli; Heather Thiessen-Philbrook; Immaculate Nevis; Arthur V. Iansavichus; Amit X. Garg

Whether renal dysfunction is an important factor in postoperative risk assessment has been difficult to prove. In an attempt to provide more compelling evidence, we conducted a systematic review comparing the risk of death and cardiac events in patients with and without chronic kidney disease who underwent elective noncardiac surgery. From electronic databases, web search engines, and bibliographies, 31 cohort studies were selected, evaluating postoperative outcomes in patients with chronic kidney disease. These patients had higher risks of postoperative death and cardiovascular events compared to those with preserved renal function. The pooled incidence of postoperative death was significantly less in those with preserved renal function than in those patients with chronic kidney disease. Meta-regression showed a graded relationship between disease severity and postoperative death. In adjusted analysis, chronic kidney disease had a similar strength of association with postoperative death as diabetes, stroke, and coronary disease. Our review identifies chronic kidney disease as an independent risk factor for postoperative death and cardiovascular events after elective, noncardiac surgery.


Clinical Journal of The American Society of Nephrology | 2009

Optimal Method of Coronary Revascularization in Patients Receiving Dialysis: Systematic Review

Immaculate Nevis; Anna T. Mathew; Richard J. Novick; Chirag R. Parikh; Philip J. Devereaux; Madhu K. Natarajan; Arthur V. Iansavichus; Meaghan S. Cuerden; Amit X. Garg

BACKGROUND AND OBJECTIVES Patients receiving dialysis have a high burden of cardiovascular disease. Some receive coronary artery revascularization but the optimal method is controversial. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS The authors reviewed any randomized controlled trial or cohort study of 10 or more patients receiving maintenance dialysis which compared coronary artery bypass graft (CABG) to percutaneous intervention (PCI) for revascularization of the coronary arteries. The primary outcomes were short-term (30 d or in-hospital) and long-term (at least 1 year) mortality. RESULTS Seventeen studies were found. There were no randomized trials: all were retrospective cohort studies from years 1977 to 2002. There were some baseline differences between the groups receiving CABG compared with those receiving PCI, and most studies did not consider results adjusted for such characteristics. Given the variability among studies and their methodological limitations, few definitive conclusions about the optimal method of revascularization could be drawn. In an exploratory meta-analysis, short-term mortality was higher after CABG compared to PCI. A substantial number of patients died over a subsequent 1 to 5 yr, with no difference in mortality after CABG compared to PCI. CONCLUSIONS Although decisions about the optimal method of coronary artery revascularization in dialysis patients are undertaken routinely, it was surprising to see how few data has been published in this regard. Additional research will help inform physician and patient decisions about coronary artery revascularization.


Circulation-cardiovascular Imaging | 2014

Prevalence of Myocardial Fibrosis Patterns in Patients With Systolic Dysfunction Prognostic Significance for the Prediction of Sudden Cardiac Arrest or Appropriate Implantable Cardiac Defibrillator Therapy

Fahad Almehmadi; Sebastien Xavier Joncas; Immaculate Nevis; Mohammad Zahrani; Mahmoud Bokhari; John Stirrat; Nowell Fine; Raymond Yee; James A. White

Background—Late gadolinium enhancement-cardiac magnetic resonance is increasingly performed in patients with systolic dysfunction. Numerous patterns of fibrosis are commonly reported among this population. However, the relative prevalence and prognostic significance of these findings remains uncertain. Methods and Results—Three hundred eighteen consecutive patients referred for late gadolinium enhancement-cardiac magnetic resonance and a left ventricular ejection fraction <55% were followed up for the primary end point of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy. Late gadolinium enhancement images were blindly interpreted for the presence of 6 distinct pattern(s) of myocardial fibrosis in addition to signal threshold-based quantification of total fibrosis volume. The mean age and left ventricular ejection fraction of participants were 62.0±12.9 years and 32.6±11.9%, respectively. Any pattern of myocardial fibrosis was seen in 248 patients (78%) with ≥2 patterns present in 25% of patients. During follow-up (median of 467 days), 49 patients (15%) had a primary outcome. After adjustment for left ventricular ejection fraction, cardiomyopathy pathogenesis, and total fibrosis volume, the presence of a midwall striae pattern of fibrosis was an independent predictor of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy with a hazard ratio of 2.4 (95% confidence interval, 1.2–4.6; P=0.01); this finding is present in 30% of patients with nonischemic and 15% of patients with ischemic cardiomyopathy. Cumulative event rate was significantly higher among those with midwall striae, particularly among those with a left ventricular ejection fraction >35% (40% versus 6%; P=0.005). Conclusions—Patients with systolic dysfunction frequently demonstrate multiple patterns of myocardial fibrosis. Of these, a midwall striae pattern of fibrosis is the strongest independent predictor of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy.Background— Late gadolinium enhancement-cardiac magnetic resonance is increasingly performed in patients with systolic dysfunction. Numerous patterns of fibrosis are commonly reported among this population. However, the relative prevalence and prognostic significance of these findings remains uncertain. Methods and Results— Three hundred eighteen consecutive patients referred for late gadolinium enhancement-cardiac magnetic resonance and a left ventricular ejection fraction 35% (40% versus 6%; P =0.005). Conclusions— Patients with systolic dysfunction frequently demonstrate multiple patterns of myocardial fibrosis. Of these, a midwall striae pattern of fibrosis is the strongest independent predictor of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy.


Nephron Clinical Practice | 2007

Do Biochemical Measures Change in Living Kidney Donors

Ann Young; Immaculate Nevis; Colin C. Geddes; John S. Gill; Neil Boudville; Leroy Storsley; Amit X. Garg

Background: Living kidney donation provides a unique opportunity to assess possible biochemical changes attributable to small decrements in glomerular filtration rate. We reviewed studies which followed 5 or more healthy donors, where changes in biochemical measures or anemia were assessed at least 4 months after nephrectomy. Methods: We searched MEDLINE, EMBASE, and Science Citation databases, and reviewed reference lists from 1966 through June 2006. We abstracted data on study and donor characteristics and biochemical outcomes of interest. Results: Eight studies examined at least one outcome of interest. The average time after donation ranged from 0.4 to 11 years, the postdonation creatinine clearance ranged from 73 to 99 ml/min, and the decrement after donation ranged from 11 to 38 ml/min. Nephrectomy did not change hemoglobin, erythropoietin, serum phosphate, calcium or C-reactive protein levels. The studies were inconsistent as to whether parathyroid hormone levels increased and 1,25-dihydroxyvitamin D levels decreased after nephrectomy. Uric acid levels increased variably post-donation. Plasma homocysteine increased in the single study included in this review. Conclusions: The mechanistic changes described above and their prognostic significance need clarification. Based on existing evidence, it is not necessary to routinely monitor living kidney donors for changes in these biochemical measures.


American Journal of Transplantation | 2009

Maternal and fetal outcomes after living kidney donation.

Immaculate Nevis; Amit X. Garg

Women considering kidney donation frequently ask whether a nephrectomy will impact their ability to have children. Two new studies consider this issue. We place the new information in the context of previous literature and practice guidelines, and discuss how we should counsel and care for our donors in the year 2009.


Pediatric Transplantation | 2013

Adolescent classroom education on knowledge and attitudes about deceased organ donation: A systematic review

Alvin Ho-ting Li; Amanda M. Rosenblum; Immaculate Nevis; Amit X. Garg

In many countries, adolescents can choose to register a deceased organ donation wish when they apply for a drivers license. They often receive education about deceased organ donation in order to make an informed choice. The objective of this review was to describe the effectiveness of school‐based educational programs on deceased organ donation among adolescents. We reviewed any study of adolescent students receiving a school‐based educational program on deceased organ donation. The outcomes were knowledge, attitudes, intent to register a preference toward deceased organ donation, and whether such education fostered family discussions about organ donation. Fifteen studies were summarized from nine countries, of which six were randomized controlled trials. Most educational programs consisted of one or two classroom sessions. The methods employed in five studies received a high‐quality rating. Educational programs increased knowledge in 10 studies, and attitudes in five studies, with variable effects on intent to affirmative registration. Seven studies reported success in promoting family discussions. Adolescent classroom education is a promising strategy to improve knowledge about deceased organ donation and appears to increase public support for donation. Subjecting these programs to additional evaluation will clarify their impact on affirmative donor registration and realized donations.


Nephrology Dialysis Transplantation | 2014

Living kidney donor estimated glomerular filtration rate and recipient graft survival

Ann Young; S. Joseph Kim; Amit X. Garg; Anjie Huang; Greg Knoll; G. V. Ramesh Prasad; Darin Treleaven; Charmaine E. Lok; Jennifer Arnold; Neil Boudville; Ann Bugeya; Christine Dipchand; Mona D. Doshi; Liane S. Feldman; Amit Gerg; Colin C. Geddes; Eric M. Gibney; John S. Gill; Martin Karpinski; Joseph Kim; Scott Klarenbach; Charmaine Laok; Philip A. McFarlane; Mauricio Monroy-Cuadros; Norman Muirhead; Immaculate Nevis; Christopher Y. Nguan; Chirag R. Parikh; Emilio D. Poggio; Leroy Storsley

BACKGROUND Kidney transplants from living donors with an estimated glomerular filtration rate (eGFR) < 80 mL/min per 1.73 m(2) may be at risk for increased graft loss compared with a recipient who receives a kidney from a living donor with a higher eGFR. METHODS This retrospective cohort study considered 2057 living kidney donors and their recipients from July 1993 to March 2010 at five centres in Ontario, Canada, and linked them to population-based, universal healthcare databases. Recipients were divided into five groups based on their donors baseline eGFR. The median (inter-quartile range) for the lowest eGFR group was 73 (68-77) mL/min per 1.73 m(2). Subjects were followed for a median of 6 years (IQR: 3-10 years). RESULTS There was no significant difference in the adjusted hazard ratio (HR) for graft loss when comparing recipients in each eGFR category to the referent group (≥110 mL/min per 1.73 m(2)). The adjusted HRs (95% CI) from the lowest (<80 mL/min per 1.73 m(2)) to highest (100-109.9 mL/min per 1.73 m(2)) eGFR categories were 1.27 (0.84-1.92), 1.43 (0.96-2.14), 1.23 (0.86-1.77) and 1.23 (0.85-1.77), respectively. Similar results were observed when dichotomizing the baseline donor eGFR using a cut-point of 80 mL/min per 1.73 m(2)-adjusted HR 1.01 [95% confidence interval (95% CI) (0.76-1.44)]. CONCLUSIONS Further research in this setting should clarify whether additional tests (i.e. measured GFR) should be performed in potential donors whose eGFR is considered borderline, whether eGFR values should be standardized to body surface area, and the outcomes for donors after nephrectomy.


Journal of Clinical Hypertension | 2010

Risk of pregnancy-related hypertension within 5 years of exposure to drinking water contaminated with Escherichia coli O157:H7.

Louise Moist; Jessica M. Sontrop; Amit X. Garg; William F. Clark; Rita S. Suri; Robert Gratton; Marina Salvadori; Immaculate Nevis; Jennifer J. Macnab

J Clin Hypertens(Greenwich). 2010;12:613–620.

Collaboration


Dive into the Immaculate Nevis's collaboration.

Top Co-Authors

Avatar

Amit X. Garg

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Arunmozhi Dominic

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John Stirrat

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Harold Kim

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fahad Almehmadi

University of Western Ontario

View shared research outputs
Top Co-Authors

Avatar

Mahmoud Bokhari

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Mohammad Zahrani

London Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Raymond Yee

University of Western Ontario

View shared research outputs
Researchain Logo
Decentralizing Knowledge